Multiple sclerosis medical therapy
Bladder
Treatment objectives are aliviation of symptoms of urinary dysfunction, treatment of urinary infections, reduction of complicating factors and preservation of renal function.Treatments can be classified in two main subtypes: pharmacological and non pharmacological.
Pharmacological treatments vary greatly depending on the origin or type of dysfunction; however some examples of the medications used are:[1] alfuzosin for retention,[2] trospium and flavoxate for urgency and incontinency,[3][4] or desmopressin for nocturia.[5][6]
Non pharmacological treatments involve the use of pelvic floor muscle training, stimulation, biofeedback,pessaries, bladder retraining, and sometimes intermittent catheterization.[7]
- ↑ Ayuso-Peralta L, de Andrés C (2002). "[Symptomatic treatment of multiple sclerosis]". Revista de neurologia (in Spanish; Castilian). 35 (12): 1141–53. PMID 12497297.
- ↑ Information from the USA National library of medicine on alfuzosin[1]
- ↑ Information from the USA National library of medicine on trospium[2]
- ↑ Information from the USA National library of medicine on flavoxate [3]
- ↑ Bosma R, Wynia K, Havlíková E, De Keyser J, Middel B (2005). "Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis". Acta Neurol. Scand. 112 (1): 1–5. doi:10.1111/j.1600-0404.2005.00431.x. PMID 15932348.
- ↑ Information from the USA National library of medicine on desmopressin[4]
- ↑ Frances M Diro (2006) "Urological Management in Neurological Disease". [5]